உலகளாவிய டிஜிட்டல் கூப்பன் News Today : Breaking News, Live Updates & Top Stories | Vimarsana
SigmaLedger Enhances Coupon Validation Service by adding Universal Digital Coupon Connectivity For National and Regional Retail Chains
prweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prweb.com Daily Mail and Mail on Sunday newspapers.
FOBI AI Inc inks letter of intent to acquire US online coupon and advertising platform Qples
proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.
Fobi AI Inc : FOBI AI Signs LOI To Acquire US Based Qples Online Coupon And Advertising Platform Fully Integrates New Universal Digital Coupon Standards To Deliver Global CPG Generated Coupons Into Any Grocery, Convenience And Pharmacy Platform And Expec
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
NA Proactive news snapshot: Mydecine Innovations Group Inc, Aion Therapeutic Inc, EVmo Inc, Alpine 4 Holdings Inc, Dalrada Corporation , Ayurcann Holdings Corp, HempFusion Wellness Inc, Fireweed Zinc Ltd, Fury Gold Mines Ltd, Ridgeline Minerals Corp, AIM
proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.
A glance at some of the day s highlights from the Proactive Investors US and Canada newswires Your daily round-up from the world of Proactive
Mydecine Innovations Group Inc (NEO:MYCO) (OTCMKTS:MYCOF) (FRA:0NFA) announced that it ended the first quarter of 2021 with cash and equivalents of C$11.3 million, which the company said will help it advance its intellectual property portfolio, build out its clinical trial calendar, expand its European operations and develop its technology division. As well, Mydecine said its strategic partnerships are expected to expand its drug development capabilities to more efficiently and rapidly lead the next generation of psychedelic-assisted therapeutics.